Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles

• André F. Lima,
• Giselle Z. Justo and
• Alioscka A. Sousa

Beilstein J. Nanotechnol. 2024, 15, 1208–1226, doi:10.3762/bjnano.15.98

• signaling axis plays a crucial role in cancer development by facilitating the proliferation and invasion of tumor cells and recruiting immunosuppressive cells, thus representing a significant opportunity for targeted therapy [160]. Results from a mouse model of TNBC showed improved tumor uptake of 64Cu

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• aqueous solution, showing promising prospects for use in magnetically targeted therapy. Determination of photothermal stability and efficiency To evaluate the photothermal performance of the nanostructures, the NPs were irradiated with an 808 nm laser at a power density of 1 W/cm2 for 5 min. A slight

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• higher binding affinity and specificity, mAbs have received a lot of attention for the detection of selective cancer biomarkers and also for the treatment of various types of cancer. Antibody-conjugated nanoparticles (ACNPs) are an effective targeted therapy for the efficient delivery of

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• clinical translation prospects, and the associated challenges are discussed. Keywords: cancer cell biomimetics; nanoparticles; precision medicine; targeted therapy; theranostic nanomedicine; Review 1 Introduction Biomimetic nanotechnology, an emerging interdisciplinary field, involves different

• effectively improve antitumor efficacy [102]. The coating with cancer cell membranes can confer a more targeted therapy and longer circulation time. Through the enrichment of NPs on tumor tissues mediated by cancer cell membrane proteins, ROS will be induced to exert targeted antitumor effects. Furthermore

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

• Filip Gorachinov,
• Fatima Mraiche,
• Diala Alhaj Moustafa,
• Ola Hishari,
• Yomna Ismail,
• Jensa Joseph,
• Maja Simonoska Crcarevska,
• Marija Glavas Dodov,
• Nikola Geskovski and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23

• treatments because of their ability to target specific molecular abnormalities associated with NSCLC cells [8][9][10][11][12][13]. Unlike traditional chemotherapy, which interferes with cell division and kills rapidly dividing cells, molecularly targeted therapy is directed towards somatic genome mutations

• ][62]. Further, substantial evidence for the efficacy of EGFR TKIs combined with HER2-targeted therapy in patients with developed EGFR TKI resistance due to HER2 amplification can be found in the literature [63][64][65]. Patients with HER2 gene mutations showing resistance to EGFR TKIs may be sensitive

Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

• Sadaf Mushtaq,
• Khuram Shahzad,
• Tariq Saeed,
• Anwar Ul-Hamid,
• Bilal Haider Abbasi,
• Nafees Ahmad,
• Waqas Khalid,
• Muhammad Atif,
• Zulqurnain Ali and
• Rashda Abbasi

Beilstein J. Nanotechnol. 2021, 12, 1339–1364, doi:10.3762/bjnano.12.99

• ]. Conventional treatment strategies for cancer, including surgery, radiotherapy, and chemotherapy, lack the ability to selectively target neoplastic tissue, which results in systemic toxicity [3]. For these reasons, the focus of the field was transferred to nanomedicine which enables targeted therapy and reduces

Recent progress in actuation technologies of micro/nanorobots

• Ke Xu and
• Bing Liu

Beilstein J. Nanotechnol. 2021, 12, 756–765, doi:10.3762/bjnano.12.59

• biomedical fields, such as medical diagnosis, nanoscale surgery, and targeted therapy. In this article, recent progress on micro/nanorobots is reviewed regarding actuation technologies. First, the different actuation mechanisms are divided into two types, external field actuation and self-actuation. Then, a

• targeted therapy. This research result indicated that the use of magnetotactic bacteria is an effective method to treat cancer, and its application urgently needs more scholars to explore. Xing et al. [48] used marine-derived magnetotactic bacteria (AMB-1) as a template to build an intelligent micro

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

• Nikola Geskovski,
• Nadica Matevska-Geshkovska,
• Simona Dimchevska Sazdovska,
• Marija Glavas Dodov,
• Kristina Mladenovska and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

• condition, and genetic profile. The current treatment options include traditional chemotherapy, haematopoietic stem cell transplantation (HSCT), and targeted therapy (small molecule inhibitors and monoclonal antibodies). Traditional chemotherapeutic regimens are limited by two primary concerns: overall

• cancers [65]. It is a compelling marker of many malignances significantly associated with cancer progression, metastasis, and drug resistance. Also, EGFR is a promising molecule for targeted therapy. Different drugs against EGFR have been introduced in the clinical practice [66]. However, the efficacy of

• development and survival have fostered the parallel development of multifunctional bioactive nanomedicines capable of attacking multiple targets, which hold potential to overcome current deficiencies of targeted therapy. Targeting strategies with innovative ligands for nanoparticle surface engineering

Doxorubicin-loaded gold nanorods: a multifunctional chemo-photothermal nanoplatform for cancer management

• Uzma Azeem Awan,
• Abida Raza,
• Shaukat Ali,
• Rida Fatima Saeed and
• Nosheen Akhtar

Beilstein J. Nanotechnol. 2021, 12, 295–303, doi:10.3762/bjnano.12.24

• of death worldwide from which 9.6 million people died in 2018 [1]. Hepatocellular carcinoma (HCC) is one of the major types of liver cancer with high incidence of mortality [2]. Currently, there are a number of treatment modalities, including chemotherapy, immunotherapy, targeted therapy, irradiation

Understanding nanoparticle flow with a new in vitro experimental and computational approach using hydrogel channels

• Armel Boutchuen,
• Dell Zimmerman,
• Abdollah Arabshahi,
• John Melnyczuk and
• Soubantika Palchoudhury

Beilstein J. Nanotechnol. 2020, 11, 296–309, doi:10.3762/bjnano.11.22

• studying the flow of NPs. Iron oxide NPs are extensively investigated in targeted therapy and drug delivery applications owing to their tunable size, surface functionalities, and magnetic properties. In this study, we synthesized four different polyvinylpyrrolidone (PVP)/polyethyleneimine (PEI)-coated iron

Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting

• Xianping Liu,
• Chengjuan Du,
• Haichun Li,
• Ting Jiang,
• Zimiao Luo,
• Zhiqing Pang,
• Daoying Geng and
• Jun Zhang

Beilstein J. Nanotechnol. 2019, 10, 1860–1872, doi:10.3762/bjnano.10.181

• in vivo targeted therapy of glioblastoma. Conclusion In summary, a novel dual-modal molecular imaging capability has been created through conjugating PEPHC1 to PEGylated SPIONs, aiming to improve the sensitivity of MR imaging and the spatial resolution of optical imaging. Both the in vitro and in

Cytotoxicity of doxorubicin-conjugated poly[N-(2-hydroxypropyl)methacrylamide]-modified γ-Fe₂O₃ nanoparticles towards human tumor cells

• Zdeněk Plichta,
• Yulia Kozak,
• Rostyslav Panchuk,
• Viktoria Sokolova,
• Matthias Epple,
• Lesya Kobylinska,
• Pavla Jendelová and
• Daniel Horák

Beilstein J. Nanotechnol. 2018, 9, 2533–2545, doi:10.3762/bjnano.9.236

• ][9]. These include the presence of specific conjugated antibodies on the surface to bind selectively to related receptors and inhibit tumor growth and/or release loaded drugs for targeted therapy. This will result in increased drug concentration and accumulation at the pathological site, improved

Nano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot delivery

• Liga Saulite,
• Dominyka Dapkute,
• Karlis Pleiko,
• Ineta Popena,
• Simona Steponkiene,
• Ricardas Rotomskis and
• Una Riekstina

Beilstein J. Nanotechnol. 2017, 8, 1218–1230, doi:10.3762/bjnano.8.123

• nanoparticles in imaging and targeted therapy of tumours. Due to their tumour-homing ability, nano-engineered mesenchymal stem cells (MSCs) could be utilized as vectors to deliver diagnostic and therapeutic nanoparticles into a tumour. In the present study, uptake and functional effects of carboxyl-coated

• death worldwide [1]. Nanoparticles (NPs) could be linked to various drugs, thereby making them suitable for tumour imaging and targeted therapy [2]. However, the fact that NPs are quickly recognised by immune cells and cleared from the blood stream by reticuloendothelial system limits their utility as

Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels

• Yue Zhang and
• Wan-Xi Yang

Beilstein J. Nanotechnol. 2016, 7, 675–684, doi:10.3762/bjnano.7.60

• ]. Several modified NPs were also used in vascular-targeted therapy, which showed their way into endothelial cells and escape from the endosome in vitro [39]. Likewise, while iron oxide NPs are very helpful with their capability for imaging, their toxicity towards vascular endothelial cells cannot be ignored